Neurology
The new blood test is less invasive and more accessible to patients.
Ifetroban shows significant 12-month cardiac benefit in DMD patients, per phase-2 FIGHT DMD trial results.
Apitegromab improves motor function in SMA patients aged 2–21, per phase-3 SAPPHIRE trial results.
Losmapimod failed to show clinical benefit over placebo in FSHD patients in the phase 3 REACH trial, ending its development.
Intrathecal gene therapy OA significantly improved motor function in older SMA patients in phase-3 STEER trial.
1 in 31 U.S. kids are diagnosed with autism—what’s behind the rise? Noise Filter breaks it down, myths and all.
Nontraditional factors and patent foramen ovale status are risk factors for stroke in younger patients.
Parkinson's disease and melanoma are believed to be linked due to DNA double-strand break repair thus cell proliferation.
Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease
The primary safety endpoint of minimal SAEs was met as well as the secondary endpoint of increased fluorodopa in the putamen.
While neuroimaging has advanced with respect to autism/Down syndrome, ADHD still requires standard imaging protocols.
Dr. Anne Marie Morse breaks down somniphobia and how it can impact healthcare providers and their patients.
ALS Functional Rating Scale-Revised results scores were used to determined therapeutic efficacy versus placebo.
Advertisement
Expert Interviews in Neurology
Advertisement
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest medical updates and insights straight to your inbox.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.